Previous studies have shown that Wnt/β-catenin signaling promoters such as Wnt1, Wnt2 and Wnt3a are associated with tumor proliferation and angiogenesis in NSCLC [46–49]. The gene discussed is WNT2; the disease is non-small cell lung carcinoma.